Showing results (631-640 of 680) with videos related to
Sort By:
Pageof 68
Neuroscience Letters|May 4, 2010
Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorderRosie M Walker, Andrea Christoforou, Pippa A Thomson, et al.Conservation Biology : the Journal of the Society for Conservation Biology|October 17, 2024
Challenges in assessing the effects of environmental governance systems on conservation outcomesRaphael A Ayambire, Trina Rytwinski, Jessica J Taylor, et al.Psychiatric Genetics|April 23, 2010
Support for a bipolar affective disorder susceptibility locus on chromosome 12q24.3Henriette Nørmølle Buttenschøn, Henriette Nørmølle Buttenchøn, Leslie Foldager, et al.Genomics|February 15, 2001
A 6.9-Mb high-resolution BAC/PAC contig of human 4p15.3-p16.1, a candidate region for bipolar affective disorderK L Evans, S Le Hellard, S W Morris, et al.Research Square|July 3, 2026
Prefrontal Circuitry Abnormalities and Cognitive Impairment in Adolescents with Early- Onset PsychosisHanne Van Der Heijden, Saad Rahmat, Amanda Cao, et al.Genetics in Medicine Open|May 25, 2026
Evaluating and monitoring liver disease severity in glycogen storage disease type IX: Performance of novel and established clinical scoresAnna Paschall, Rebecca L Koch, Alisha M Mavis, et al.Journal of Hepatology|October 27, 2019
Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trialGregory J Dore, Jordan J Feld, Alex Thompson, et al.Journal of Hepatology|November 12, 2018
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trialGideon M Hirschfield, Olivier Chazouillères, Joost P Drenth, et al.Hepatology (Baltimore, Md.)|April 18, 2019
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab TrialsArun J Sanyal, Stephen A Harrison, Vlad Ratziu, et al.Gastroenterology|October 12, 2014
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantationMichael Charlton, Edward Gane, Michael P Manns, et al.Pageof 68